These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9558362)

  • 1. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.
    Barbui T; Finazzi G; Falanga A
    Blood; 1998 May; 91(9):3093-102. PubMed ID: 9558362
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulopathy of acute promyelocytic leukemia.
    Falanga A; Barbui T
    Acta Haematol; 2001; 106(1-2):43-51. PubMed ID: 11549776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
    Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute promyelocytic leukaemia in the all trans retinoic acid era.
    DeLoughery TG; Goodnight SH
    Med Oncol; 1996 Dec; 13(4):233-40. PubMed ID: 9152974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy.
    Pogliani EM; Rossini F; Casaroli I; Maffe P; Corneo G
    Acta Haematol; 1997; 97(4):228-30. PubMed ID: 9158667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy.
    Incerpi MH; Miller DA; Posen R; Byrne JD
    Obstet Gynecol; 1997 May; 89(5 Pt 2):826-8. PubMed ID: 9166337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
    Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
    Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of recombinant human soluble thrombomodulin in induction therapy for acute promyelocytic leukemia.
    Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H
    Thromb Res; 2021 Jun; 202():173-175. PubMed ID: 33866226
    [No Abstract]   [Full Text] [Related]  

  • 9. [Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia].
    Korístek Z; Zák P
    Vnitr Lek; 2008; 54(7-8):745-50. PubMed ID: 18780573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia.
    Gillis S; Dann EJ; Eldor A
    Eur J Haematol; 1995 Jan; 54(1):59-60. PubMed ID: 7859878
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disseminated intravascular coagulation in malignant neoplasms].
    Kato A
    Rinsho Ketsueki; 2010 Jan; 51(1):37-43. PubMed ID: 20134138
    [No Abstract]   [Full Text] [Related]  

  • 13. [Successful remission induction with reduced-dose all-trans retinoic acid for acute promyelocytic leukemia complicated by COVID-19].
    Fujimoto R; Kamae T; Kamijo K; Yasumi M; Karasuno T
    Rinsho Ketsueki; 2024; 65(6):498-501. PubMed ID: 38960647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombosis and DIC in hematological malignancies].
    Asakura H
    Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
    [No Abstract]   [Full Text] [Related]  

  • 15. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
    Falanga A; Rickles FR
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
    Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
    Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in the management of coagulopathy in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia.
    Kawai Y; Watanabe K; Kizaki M; Murata M; Kamata T; Uchida H; Moriki T; Yokoyama K; Tokuhira M; Nakajima H
    Am J Hematol; 1994 Jul; 46(3):184-8. PubMed ID: 8192147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.